jzs-10747

Evaluation of Radiation Doses Received by Organs at Risk in 3D Conformal and Intensity Modulated Radiotherapy for Head and Neck Cancer

Hunar A. Hassan1, Kharman A.  Faraj2, Zarean Y. Saeed1

1 Zhianawa Cancer Center, Sualimani City, Kurdistan Region, Iraq

2 Department of Physics, College of Science, University of Sulamani, Kurdistan Region, Iraq

Original: 30 October 2018, Revised: 20 January 2019, Accepted: 17 February 2019, Published online: 20 June 2019  

DOI Link: https://doi.org/10.17656/jzs.10747

Abstract

The purpose of this study was to evaluate the doses delivered to the critical structures located close to the target volume during head and neck radiotherapy by 3D-CRT and IMRT technics in order to select possible treatment technic proper to head and neck regions. We have used all data collected from the Treatment Planning Systems (TPS) to conduct a pilot comparison between the two modalities. The comparison included the parameters of the target coverage, dose conformity and homogeneity for the planning target volume (PTV), the maximum and mean doses for organs at risk (OARs), the time required to deliver the prescribed dose, and number of Monitor Units (MU). The results showed that the dose conformity with IMRT plans for both PTV high and low risk was significantly better than those obtained with 3D-CRT plan. The dose uniformity in the PTV low risk was better with IMRT plan; mean homogeneity Index (HI) was 37.476 but for 3D-CRT were 43.465. IMRT technic achieved better PTV coverage. IMRT tended to provide a significant better OAR avoidance than 3D-CRT. We concluded that the 3D-CRT plan could not provide adequate OAR avoidance where many OARs are close to the PTVs. The IMRT plan, even though it takes longer time and more MUs, is the optimal plan for head and neck cancer treatment that derives to a better outcome while avoiding complication in the surrounded normal tissue.

Key Words:  Intensity modulated radiotherapy, three-dimensional conformal radiation therapy, head and neck cancer, radiation dose, organs at risk

    References

[[1] Bardely R. Pieters, Djuna Z. de Back, Caro C.C Koning  and Aeliko H. Zwinderman. "Comparison of three radiotherapy modalities on biochemical control and overall survival for the treatment of prostate cancer: a systematic review", Radiotherapy and Oncology. Vol. 93, No. 2, pp. -173. (2009).

[2] Feldmann, H.J., Kneschaurek, P. and Molls M., "Three-dimensional Radiation Treatment: Technological Innovations and Clinical Results", Karger Medical and Scientific Publishers. Vol. 34. (2000).

[3] Lynn J. Verhey,  "January. Comparison of three-dimensional conformal radiation therapy and intensity-modulated radiation therapy systems". Seminars in Radiation Oncology. Vol. 9, No. 1, pp. 78-98. (1999).

[4] Márcio Lemberg Reisner, Célia Maria Pais Viégas, Rachele Zanchet Grazziotin, Delano Valdivino Santos Batist, Túlio Meneses Carneiro, Carlos Manoel Mendonça de Araújo, Edson Marchiori, "Retinoblastoma—comparative analysis of external radiotherapy techniques, including an IMRT technique". International Journal of Radiation Oncology Biology. Physics. Vol. 67, No. 3, pp.933-941. (2007).

[5] M. Kara Bucci, Alison Bevan and Mack Roack, "Advances in radiation therapy: conventional to 3D, to IMRT, to 4D, and beyond", CA: a cancer journal for clinicians. Vol. 55, No. 2, pp.117-134. (2005).

[6] Laurence E Court, Peter Balter, and Radhe Mohan, "Principles of IMRT. In Intensity-Modulated Radiation Therapy", Springer Japan. pp. 15-42. (2015).

[7] Fazi M. Khan and Bruce John Gerbi, "Treatment planning in radiation oncology". 3rd edition, Philadelphia, Wolters Kluwer/Lippincott Williams & Wilkins Health. (2012).

[8] Bernier  J. Head and neck cancer: multimodality management. New York, Springer. (2011).

[9] Argiris A, Karamouzis MV, Raben D, Ferris RL. "Head and neck cancer". The Lancet. Vol. 371, pp. 1695-1709. (2008).

[10] Johannes A. Langendijk, Patricia Doornaert, Irma M. Verdonck-de Leeuw, Charles R. Leemans, Neil K. Aaronson, and Ben J. Slotman, "Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy", Journal of clinical oncology. Vol. 26, No. 22, pp.3770-3776. (2008).

[11] Kostas N. Syrigos, Dimitris Karachaliosd, Eleni M. Karapanagiotoue, Christopher M. Nuttinge, Leonidas Manolopoulosf, Kevin J. Harringtone, "Head and neck cancer in the elderly: an overview on the treatment modalities", Cancer treatment reviews. Vol. 35, No. 3, pp.237-245. (2009).

[12] Candela F.C., Kothari K. and Shah JP., "Patterns of cervical node metastases from squamous carcinoma of the oropharynx and hypopharynx", Head  Neck. Vol. 12, No. 3, pp.197-203. (1990).

[13] Jatin P. Shah, Franck C. Candela, Anil K. Poddar, "The patterns of cervical lymph node metastases from squamous carcin oma of the oral cavity", Cancer, Vol. 66, No. 1, pp. 109-113. (1990).

[14] ICRU Report 62, "Prescribing, Recording and Reporting Photon-Beam Therapy", Supplement to ICRU Report 50). (1993).

[15] Marks, L.B., Yorke, E.D., Jackson, A., Ten Haken, R.K., Constine, L.S., Eisbruch, A., Bentzen, S.M., Nam, J. and Deasy, J.O., "Use of normal tissue complication probability models in the clinic", International Journal of Radiation Oncology Biology. Physics. Vol. 76, No. 3, pp. S10-S19. (2010).

[16] Emami, B., "Tolerance of normal tissue to therapeutic radiation", Reports of radiotherapy and Oncology. Vol. 1, No. 1. (2013).

[17] William M. Mendenhall, Robert J. Amdur, Jatinder R. Palta , "Intensity-modulated radiotherapy in the standard management of head and neck cancer: promises and pitfalls". Journal of clinical oncology. Vol. 24, No. 17, pp.2618-2623. (2006).

[18] Petra M. Bram, Chris H.J. Terhaard, Judith M. Roesink, Cornelis P.J. Raaijmakers, "Intensity-modulated radiotherapy significantly reduces xerostomia compared with conventional radiotherapy", International Journal of Radiation Oncology Biology Physics. Vol. 66, No. 4, pp.975-980. (2006).

[19] Leire Arbea, Luis Isaac Ramos, Rafael Martínez-Monge , Marta Moreno,Javier Aristu, "Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): dosimetric comparison and clinical implications", Radiation Oncology. Vol. 5, No. 1, p.17. (2010).

[20] Nancy Lee, Ping Xia, Jeanne M. Quivey, Khalil Sultanem, Ian Poon, Clayton Akazawa, Pam Akazawa, Viviian Weinberg, Karen K.Fu, "Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience", International Journal of Radiation Oncology * Biology* Physics. Vol. 53, No. 1, pp.12-22. (2002).

[21] Fiandra, C., Filippi, A.R., Catuzzo, P., Botticella, A., Ciammella, P., Franco, P., Borca, V.C., Ragona, R., Tofani, S., Ricardi, U., "Different IMRT solutions vs. 3D-conformal radiotherapy in early stage Hodgkin’s Lymphoma: dosimetric comparison and clinical considerations", Radiation Oncology. Vol. 7, No. 1, p.186. (2012).

[22] Edvard Abel, Ewa Silander, Jan Nyman,Mogens  Bove, Leif Johansson, Thomas Björk-Eriksson, Eva Hammerlid, "Impact on quality of life of IMRT versus 3-D conformal radiotherapy in head and neck cancer patients: A case-control study". Advances in Radiation Oncology. (2017).

[23] Andrea Pirzkall, Frank Lohr, Angelika Höss, A., M Wannenmacher, Jurgen Debus, Mark Carol, "Comparison of intensity-modulated radiotherapy with conventional conformal radiotherapy for complex-shaped tumors", International Journal of Radiation Oncology Biology Physics. Vol. 48, No. 5, pp.1371-1380. (2000).

Full Text

     Copyright (c) 2018 : Hunar A. Hassan, Kharman A.  Faraj, Zarean Y. Saeed

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.